SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure
Abstract Background Glucocorticoids could greatly improve the prognosis of patients with acute-on-chronic hepatitis B liver failure (ACHBLF). Suppressor of cytokine signaling (SOCS) 1 methylation has been shown to be associated with mortality in ACHBLF. Methods Eighty patients with ACHBLF were divid...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-05-01
|
| Series: | Clinical Epigenetics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13148-023-01495-9 |
| _version_ | 1797832042951475200 |
|---|---|
| author | Feng Li Ying Zhang Zhao-Hui Wang Shuai Gao Yu-Chen Fan Kai Wang |
| author_facet | Feng Li Ying Zhang Zhao-Hui Wang Shuai Gao Yu-Chen Fan Kai Wang |
| author_sort | Feng Li |
| collection | DOAJ |
| description | Abstract Background Glucocorticoids could greatly improve the prognosis of patients with acute-on-chronic hepatitis B liver failure (ACHBLF). Suppressor of cytokine signaling (SOCS) 1 methylation has been shown to be associated with mortality in ACHBLF. Methods Eighty patients with ACHBLF were divided into group glucocorticoid (GC) and group conservative medical (CM). Sixty patients with chronic hepatitis B (CHB), and Thirty healthy controls (HCs) served as control group. SOCS1 methylation levels in peripheral mononuclear cells (PBMCs) was detected by MethyLight. Results SOCS1 methylation levels were significantly higher in patients with ACHBLF than those with CHB and HCs (P < 0.01, respectively). Nonsurvivors showed significantly higher SOCS1 methylation levels (P < 0.05) than survivors in both GC and CM groups in ACHBLF patients. Furthermore, the survival rates of the SOCS1 methylation-negative group were significantly higher than that of the methylation-positive group at 1 month (P = 0.014) and 3 months (P = 0.003) follow-up. Meanwhile, GC group and CM group had significantly lower mortality at 3 months, which may be related to application of glucocorticoid. In the SOCS1 methylation-positive group, the 1-month survival rate was significantly improved, which may be related to GC treatment (P = 0.020). However, no significant difference could be observed between the GC group and CM group in the methylation-negative group (P = 0.190). Conclusions GC treatment could decrease the mortality of ACHBLF and SOCS1 methylation levels might serve as prognostic marker for favorable response to glucocorticoid treatment. |
| first_indexed | 2024-04-09T14:01:24Z |
| format | Article |
| id | doaj.art-af9e4ef4e71644d782d289480e275557 |
| institution | Directory Open Access Journal |
| issn | 1868-7083 |
| language | English |
| last_indexed | 2024-04-09T14:01:24Z |
| publishDate | 2023-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Clinical Epigenetics |
| spelling | doaj.art-af9e4ef4e71644d782d289480e2755572023-05-07T11:16:25ZengBMCClinical Epigenetics1868-70832023-05-0115111010.1186/s13148-023-01495-9SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failureFeng Li0Ying Zhang1Zhao-Hui Wang2Shuai Gao3Yu-Chen Fan4Kai Wang5Department of Hepatology, Qilu Hospital of Shandong UniversityDepartment of Hepatology, Qilu Hospital of Shandong UniversityDepartment of Hepatology, Qilu Hospital of Shandong UniversityDepartment of Hepatology, Qilu Hospital of Shandong UniversityDepartment of Hepatology, Qilu Hospital of Shandong UniversityDepartment of Hepatology, Qilu Hospital of Shandong UniversityAbstract Background Glucocorticoids could greatly improve the prognosis of patients with acute-on-chronic hepatitis B liver failure (ACHBLF). Suppressor of cytokine signaling (SOCS) 1 methylation has been shown to be associated with mortality in ACHBLF. Methods Eighty patients with ACHBLF were divided into group glucocorticoid (GC) and group conservative medical (CM). Sixty patients with chronic hepatitis B (CHB), and Thirty healthy controls (HCs) served as control group. SOCS1 methylation levels in peripheral mononuclear cells (PBMCs) was detected by MethyLight. Results SOCS1 methylation levels were significantly higher in patients with ACHBLF than those with CHB and HCs (P < 0.01, respectively). Nonsurvivors showed significantly higher SOCS1 methylation levels (P < 0.05) than survivors in both GC and CM groups in ACHBLF patients. Furthermore, the survival rates of the SOCS1 methylation-negative group were significantly higher than that of the methylation-positive group at 1 month (P = 0.014) and 3 months (P = 0.003) follow-up. Meanwhile, GC group and CM group had significantly lower mortality at 3 months, which may be related to application of glucocorticoid. In the SOCS1 methylation-positive group, the 1-month survival rate was significantly improved, which may be related to GC treatment (P = 0.020). However, no significant difference could be observed between the GC group and CM group in the methylation-negative group (P = 0.190). Conclusions GC treatment could decrease the mortality of ACHBLF and SOCS1 methylation levels might serve as prognostic marker for favorable response to glucocorticoid treatment.https://doi.org/10.1186/s13148-023-01495-9Acute-on-chronic hepatitis B liver failureDNA methylationGlucocorticoidMethyLightPrognosisSOCS1 |
| spellingShingle | Feng Li Ying Zhang Zhao-Hui Wang Shuai Gao Yu-Chen Fan Kai Wang SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure Clinical Epigenetics Acute-on-chronic hepatitis B liver failure DNA methylation Glucocorticoid MethyLight Prognosis SOCS1 |
| title | SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure |
| title_full | SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure |
| title_fullStr | SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure |
| title_full_unstemmed | SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure |
| title_short | SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure |
| title_sort | socs1 methylation level is associated with prognosis in patients with acute on chronic hepatitis b liver failure |
| topic | Acute-on-chronic hepatitis B liver failure DNA methylation Glucocorticoid MethyLight Prognosis SOCS1 |
| url | https://doi.org/10.1186/s13148-023-01495-9 |
| work_keys_str_mv | AT fengli socs1methylationlevelisassociatedwithprognosisinpatientswithacuteonchronichepatitisbliverfailure AT yingzhang socs1methylationlevelisassociatedwithprognosisinpatientswithacuteonchronichepatitisbliverfailure AT zhaohuiwang socs1methylationlevelisassociatedwithprognosisinpatientswithacuteonchronichepatitisbliverfailure AT shuaigao socs1methylationlevelisassociatedwithprognosisinpatientswithacuteonchronichepatitisbliverfailure AT yuchenfan socs1methylationlevelisassociatedwithprognosisinpatientswithacuteonchronichepatitisbliverfailure AT kaiwang socs1methylationlevelisassociatedwithprognosisinpatientswithacuteonchronichepatitisbliverfailure |